Mikel García-Puga

534 total citations
12 papers, 389 citations indexed

About

Mikel García-Puga is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Mikel García-Puga has authored 12 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Mikel García-Puga's work include Genetic Neurodegenerative Diseases (5 papers), Muscle Physiology and Disorders (4 papers) and Mitochondrial Function and Pathology (3 papers). Mikel García-Puga is often cited by papers focused on Genetic Neurodegenerative Diseases (5 papers), Muscle Physiology and Disorders (4 papers) and Mitochondrial Function and Pathology (3 papers). Mikel García-Puga collaborates with scholars based in Spain, United States and Brazil. Mikel García-Puga's co-authors include Ander Matheu, Adolfo López de Munaín, Estefanía Carrasco‐García, Roberto Fernández‐Torrón, Ander Saenz‐Antoñanzas, Marcos J. Araúzo‐Bravo, Juliana C. Santos, Paula Aldaz, Ana Aiastui and María Goicoechea and has published in prestigious journals such as Neurology, Cancer Research and Scientific Reports.

In The Last Decade

Mikel García-Puga

12 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikel García-Puga Spain 10 294 157 90 71 66 12 389
Simona Dalin United States 9 311 1.1× 81 0.5× 130 1.4× 102 1.4× 18 0.3× 13 419
Scott Ditch United States 5 378 1.3× 102 0.6× 76 0.8× 80 1.1× 17 0.3× 8 475
Stéphanie Verbeke France 10 179 0.6× 93 0.6× 55 0.6× 123 1.7× 26 0.4× 12 369
Aymeric Ravel‐Chapuis Canada 15 498 1.7× 217 1.4× 44 0.5× 23 0.3× 55 0.8× 30 567
Svetlana Baranovskaya United States 9 288 1.0× 63 0.4× 89 1.0× 78 1.1× 21 0.3× 10 492
Xiang Lin China 10 211 0.7× 119 0.8× 32 0.4× 31 0.4× 23 0.3× 33 369
Gloria V. Echeverria United States 9 239 0.8× 74 0.5× 104 1.2× 107 1.5× 23 0.3× 19 357
Sana Sfar Tunisia 8 185 0.6× 43 0.3× 117 1.3× 72 1.0× 63 1.0× 12 318
Simona Donatello Ireland 10 278 0.9× 96 0.6× 95 1.1× 85 1.2× 19 0.3× 11 430
Maja Sirotković-Skerlev Croatia 10 145 0.5× 95 0.6× 53 0.6× 81 1.1× 24 0.4× 20 319

Countries citing papers authored by Mikel García-Puga

Since Specialization
Citations

This map shows the geographic impact of Mikel García-Puga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikel García-Puga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikel García-Puga more than expected).

Fields of papers citing papers by Mikel García-Puga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikel García-Puga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikel García-Puga. The network helps show where Mikel García-Puga may publish in the future.

Co-authorship network of co-authors of Mikel García-Puga

This figure shows the co-authorship network connecting the top 25 collaborators of Mikel García-Puga. A scholar is included among the top collaborators of Mikel García-Puga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikel García-Puga. Mikel García-Puga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
García-Puga, Mikel, Ander Saenz‐Antoñanzas, Ander Matheu, & Adolfo López de Munaín. (2022). Targeting Myotonic Dystrophy Type 1 with Metformin. International Journal of Molecular Sciences. 23(5). 2901–2901. 14 indexed citations
2.
García-Puga, Mikel, Ander Saenz‐Antoñanzas, Gorka Gereñu, et al.. (2022). Senescence plays a role in myotonic dystrophy type 1. JCI Insight. 7(19). 13 indexed citations
3.
Aldaz, Paula, Ander Saenz‐Antoñanzas, Mikel García-Puga, et al.. (2020). SOX9 promotes tumor progression through the axis BMI1-p21CIP. Scientific Reports. 10(1). 357–357. 32 indexed citations
4.
García-Puga, Mikel, Ander Saenz‐Antoñanzas, Roberto Fernández‐Torrón, Adolfo López de Munaín, & Ander Matheu. (2020). Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin. Aging. 12(7). 6260–6275. 36 indexed citations
5.
Wang, Youjin, Ana F. Best, Roberto Fernández‐Torrón, et al.. (2019). Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study. Annals of Clinical and Translational Neurology. 7(1). 126–131. 5 indexed citations
6.
Carrasco‐García, Estefanía, et al.. (2018). Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer. Therapeutic Advances in Medical Oncology. 10. 3861409668–3861409668. 17 indexed citations
7.
Carrasco‐García, Estefanía, María Álvarez‐Satta, Mikel García-Puga, et al.. (2018). Therapeutic relevance of SOX9 stem cell factor in gastric cancer. Expert Opinion on Therapeutic Targets. 23(2). 143–152. 15 indexed citations
8.
Santos, Juliana C., Estefanía Carrasco‐García, Mikel García-Puga, et al.. (2016). SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression. Cancer Research. 76(22). 6735–6746. 96 indexed citations
9.
Fernández‐Torrón, Roberto, Mikel García-Puga, Miren Zulaica, et al.. (2016). Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation. Neurology. 87(12). 1250–1257. 43 indexed citations
10.
Carrasco‐García, Estefanía, Juliana C. Santos, Idoia García, et al.. (2016). Paradoxical role of SOX2 in gastric cancer.. PubMed. 6(4). 701–13. 39 indexed citations
11.
García-Puga, Mikel, et al.. (2015). ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins. Bioscience Reports. 35(3). 5 indexed citations
12.
Goicoechea, María, Ana Aiastui, Roberto Fernández‐Torrón, et al.. (2015). Muscle wasting in myotonic dystrophies: a model of premature aging. Frontiers in Aging Neuroscience. 7. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Dalin Breakdown of academic impact, for papers by Scott Ditch Breakdown of academic impact, for papers by Stéphanie Verbeke Breakdown of academic impact, for papers by Aymeric Ravel‐Chapuis Breakdown of academic impact, for papers by Svetlana Baranovskaya Breakdown of academic impact, for papers by Xiang Lin Breakdown of academic impact, for papers by Gloria V. Echeverria Breakdown of academic impact, for papers by Sana Sfar Breakdown of academic impact, for papers by Simona Donatello Breakdown of academic impact, for papers by Maja Sirotković-Skerlev
Rankless by CCL
2026